Cargando…
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial
BACKGROUND: The purpose of this work was to describe the efficacy and safety of a telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) single-pill combination therapy in patients with moderate-severe hypertension (mean seated trough cuff systolic blood pressure [BP] ≥ 160 mmHg and diastolic BP ≥...
Autores principales: | Zhu, Dingliang, Bays, Harold, Gao, Pingjin, Mattheus, Michaela, Voelker, Birgit, Ruilope, Luis M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636767/ https://www.ncbi.nlm.nih.gov/pubmed/23637556 http://dx.doi.org/10.2147/IBPC.S33104 |
Ejemplares similares
-
Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial
por: Bays, Harold, et al.
Publicado: (2013) -
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
por: Segura, Julian, et al.
Publicado: (2013) -
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
por: Higaki, Jitsuo, et al.
Publicado: (2017) -
Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015) -
Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
por: Baumgart, Peter, et al.
Publicado: (2011)